US Stock MarketDetailed Quotes
PULM Pulmatrix
- 6.120
- +0.010+0.16%
Close Nov 22 16:00 ET
- 6.120
- 0.0000.00%
Post 20:02 ET
22.35MMarket Cap-2318P/E (TTM)
6.580High5.960Low119.03KVolume6.150Open6.110Pre Close740.73KTurnover3.26%Turnover RatioLossP/E (Static)3.65MShares8.44052wk High2.05P/B22.35MFloat Cap1.55052wk Low--Dividend TTM3.65MShs Float4235.000Historical High--Div YieldTTM10.15%Amplitude1.550Historical Low6.223Avg Price1Lot Size
About Pulmatrix Company
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.
Company Profile
SymbolPULM
Company NamePulmatrix
Listing DateMar 21, 2014
Founded2003
CEOMr. Peter Ludlum
MarketNASDAQ
Employees22
Fiscal Year Ends12-31
Address945 Concord Street,Suite 1217
CityFramingham
ProvinceMassachusetts
CountryUnited States of America
Zip Code01701
Phone1-888-355-4440
Websitehttp://www.pulmatrix.com
Company Executives
- Name
- Position
- Salary
- Peter Ludlum
- Interim Chief Executive Officer, Interim Chief Financial Officer and Principal Accounting Officer
- 510.22K
- Michael J. Higgins
- Chairman of the Board
- 92.97K
- Dr. Christopher Cabell, M.D.
- Independent Director
- 50.56K
- Todd Bazemore
- Independent Director
- 58.06K
- Anand Varadan
- Independent Director
- 45.56K
- Dr. Richard P. Batycky, PhD
- Independent Director
- 59.56K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data